SCHEMBL375891

SCHEMBL375891

CC(O)N([C]=O)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1996349 0.88
SCHEMBL1998039 0.83
SCHEMBL2001606 0.79 TSHR (0.35)
SCHEMBL25306 0.72
SCHEMBL1185086 0.71
SCHEMBL9727607 0.69
SCHEMBL14759385 0.67
SCHEMBL277204 0.67
Isopropyl Alcohol SCHEMBL1281456 0.65 ALDH1A1 (0.60)
Isopropyl Alcohol SCHEMBL563810 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3903826-B1 BIOMOLECULE CONJUGATES CELGENE CORP (US) 2024-05-08 EP disclosed
EP-4289483-A2 BIOMOLECULE CONJUGATES Celgene Corporation (US) 2023-12-13 EP disclosed
EP-3903826-A1 BIOMOLECULE CONJUGATES Celgene Corporation (US) 2021-11-03 EP disclosed
US-10335495-B2 Biomolecule conjugates CELGENE CORPORATION (US) 2019-07-02 US disclosed
US-20170360952-A1 BIOMOLECULE CONJUGATES CELGENE CORPORATION 2017-12-21 US disclosed
EP-3226910-A1 BIOMOLECULE CONJUGATES Celgene Corporation (US) 2017-10-11 EP disclosed
WO-2016090157-A1 BIOMOLECULE CONJUGATES CELGENE CORPORATION (US) 2016-06-09 WO disclosed
EP-2275413-B1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders NOVARTIS AG (CH) 2013-03-06 EP disclosed
US-8263590-B2 Pyrimidine derivatives NOVARTIS AG (CH) 2012-09-11 US disclosed
EP-1660458-B1 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS NOVARTIS AG (CH) 2012-01-25 EP disclosed
EP-0751424-A2 Silver halide color photographic material and method for forming image FUJI PHOTO FILM CO., LTD. (JP) 1997-01-02 EP disclosed
US-5429914-A Thiosulfate free development of silver halide emulsion FUJI PHOTO FILM CO., LTD. (JP) 1995-07-04 US disclosed
US-5344750-A Color development processing method of silver halide color photographic material using a color developer where the color developing agent concentration and processing temperature are a function of bromide ion concentration FUJI PHOTO FILM CO., LTD. (JP) 1994-09-06 US disclosed
US-5298370-A Improved desilvering, nonfogging FUJI PHOTO FILM CO., LTD. (JP) 1994-03-29 US disclosed
EP-0569975-A1 Color development processing method of silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1993-11-18 EP disclosed
EP-0513766-A2 Method of processing silver halide color photographic material and photographic bleach-fixing composition FUJI PHOTO FILM CO., LTD. (JP) 1992-11-19 EP disclosed
EP-0458277-A2 Composition having a fixing ability for photography and method for processing photographic materials with the same FUJI PHOTO FILM CO., LTD. (JP) 1991-11-27 EP disclosed
US-4224025-A Process for the dyeing and printing of paper materials in different hues using a single coupling component CIBA-GEIGY CORPORATION (US) 1980-09-23 US disclosed
US-4140673-A REACTING 4-AMINO-PIPERIDINES WITH ENOLIC ETHERS BAYER AKTIENGESELLSCHAFT (DE) 1979-02-20 US disclosed
US-4065254-A DIAZO DYES, LEATHER, COTTON, WOOL CIBA-GEIGY CORPORATION (US) 1977-12-27 US disclosed